U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    MT-CO2 mitochondrially encoded cytochrome c oxidase II [ Homo sapiens (human) ]

    Gene ID: 4513, updated on 3-Nov-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Helicobacter pylori vacA affects the expression of COX-2 in the duodenal mucosa of patients with duodenitis.

    Helicobacter pylori vacA affects the expression of COX-2 in the duodenal mucosa of patients with duodenitis.
    Chu Y, Chen F, Pan Q, Cheng N, Liu X, Feng J.

    02/27/2024
    15-lipoxygenase and cyclooxygenase expression profile and their related modulators in COVID-19 infection.

    15-lipoxygenase and cyclooxygenase expression profile and their related modulators in COVID-19 infection.
    Kianfar S, Salimi V, Jahangirifard A, Mirtajani SB, Vaezi MA, Yavarian J, Mokhtari-Azad T, Tavakoli-Yaraki M.

    10/11/2023
    Elevated expression levels of COX-2, IL-8 and VEGF in colon adenocarcinoma.

    Elevated expression levels of COX-2, IL-8 and VEGF in colon adenocarcinoma.
    Uslukaya O, Yegin Z, Taskesen F, Yildirim IH.

    08/25/2023
    Interferon-gamma is quintessential for NOS2 and COX2 expression in ER[-] breast tumors that lead to poor outcome.

    Interferon-gamma is quintessential for NOS2 and COX2 expression in ER(-) breast tumors that lead to poor outcome.
    Cheng RYS, Ridnour LA, Wink AL, Gonzalez AL, Femino EL, Rittscher H, Somasundaram V, Heinz WF, Coutinho L, Rangel MC, Edmondson EF, Butcher D, Kinders RJ, Li X, Wong STC, McVicar DW, Anderson SK, Pore M, Hewitt SM, Billiar TR, Glynn SA, Chang JC, Lockett SJ, Ambs S, Wink DA., Free PMC Article

    06/2/2023
    Immunohistochemical Study and Clinicopathologic Correlation of Cox-2 and Her-2 Expression in Colorectal Carcinoma: A 5-Year Retrospective Study.

    Immunohistochemical Study and Clinicopathologic Correlation of Cox-2 and Her-2 Expression in Colorectal Carcinoma: A 5-Year Retrospective Study.
    Odukoya LA, Badmos KB, Khramtsova G, Adebayo LA, Olopade OI, Abdulkareem FB.

    12/10/2022
    Mitochondrial gene COX2 methylation and downregulation is a biomarker of aging in heart mesenchymal stem cells.

    Mitochondrial gene COX2 methylation and downregulation is a biomarker of aging in heart mesenchymal stem cells.
    Sun X, Wang Z, Cong X, Lv Y, Li Z, Rong L, Yang T, Yu D., Free PMC Article

    07/17/2021
    Mitochondrial miR-181a-5p promotes glucose metabolism reprogramming in liver cancer by regulating the electron transport chain.

    Mitochondrial miR-181a-5p promotes glucose metabolism reprogramming in liver cancer by regulating the electron transport chain.
    Zhuang X, Chen Y, Wu Z, Xu Q, Chen M, Shao M, Cao X, Zhou Y, Xie M, Shi Y, Zeng Y, Bu H.

    02/6/2021
    Novel Point Mutations in Mitochondrial MT-CO2 Gene May Be Risk Factors for Coronary Artery Disease.

    Novel Point Mutations in Mitochondrial MT-CO2 Gene May Be Risk Factors for Coronary Artery Disease.
    Heidari MM, Mirfakhradini FS, Tayefi F, Ghorbani S, Khatami M, Hadadzadeh M.

    02/2/2021
    COX-1, COX-2, and CD147 appear to be independently regulated in oral squamous cell carcinoma (OSCC), potentially representing 2 therapeutic targets for future investigation. COX-1 expression in OSCC deserves further study because it may be an important determinant of PGE2 secretion from OSCC cells

    Cyclooxygenase and CD147 expression in oral squamous cell carcinoma patient samples and cell lines.
    Nasry WHS, Wang H, Jones K, Tesch M, Rodriguez-Lecompte JC, Martin CK.

    02/1/2020
    MT-CO2 mutation m.8088delT resulting in a premature stop codon was identified in a patient with myopathy and perturbed acylcarnitine profile.

    Mitochondrial complex IV deficiency caused by a novel frameshift variant in MT-CO2 associated with myopathy and perturbed acylcarnitine profile.
    Roos S, Sofou K, Hedberg-Oldfors C, Kollberg G, Lindgren U, Thomsen C, Tulinius M, Oldfors A., Free PMC Article

    05/11/2019
    Studied Cyclooxygenase-2 (COX-2) gene polymorphisms in a Turkish population with thyroid cancer; found the COX-2-8473T>C gene polymorphism may cause genetic susceptibility to thyroid cancer as compared to the control group.

    Cyclooxygenase-2 (COX-2) gene polymorphism in patients with differentiated thyroid carcinomas in the Turkish population.
    Uçan B, Özbek M, Şahin M, Kızılgül M, Çakal E.

    01/5/2019
    Study shows that higher COX-2 and ALOX5 expression in colorectal cancer (CRC) tissues was correlated with poorer prognosis in patients with CRC. Also, MiR-216a-3p was shown to directly bind to there 3'-UTR and inversely regulates their protein levels modulating CRC cell proliferation.

    MiR-216a-3p inhibits colorectal cancer cell proliferation through direct targeting COX-2 and ALOX5.
    Wang D, Li Y, Zhang C, Li X, Yu J.

    11/3/2018
    Data suggest that mutations in MT-CO2 and MT-ND5 can be involved in MIDD (maternally inherited diabetes and deafness); a Tunisian family (mother, daughter, son) with clinical features of MIDD associated with retinopathy exhibit mutations in MT-CO2 (m.8241T>G - p. F219C) and MT-ND5 (m.13276G>A - p. M314V); these two mutations could explain retinopathy in some family members. (MT-ND5 = NADH dehydrogenase subunit 5)

    Whole mitochondrial genome screening of a family with maternally inherited diabetes and deafness (MIDD) associated with retinopathy: A putative haplotype associated to MIDD and a novel MT-CO2 m.8241T>G mutation.
    Tabebi M, Charfi N, Kallabi F, Alila-Fersi O, Ben Mahmoud A, Tlili A, Keskes-Ammar L, Kamoun H, Abid M, Mnif M, Fakhfakh F.

    03/3/2018
    Results demonstrates that the presence of high levels of COX-2 is associated with poor prognosis for breast cancer patients and predicts bigger tumor size and lymph node metastasis. [metastasis]

    Clinicopathological and prognostic significance of COX-2 immunohistochemical expression in breast cancer: a meta-analysis.
    Xu F, Li M, Zhang C, Cui J, Liu J, Li J, Jiang H., Free PMC Article

    02/24/2018
    results demonstrated that XRCC5 promoted colon cancer growth by cooperating with p300 to regulate COX-2 expression, and suggested that the XRCC5/p300/COX-2 signaling pathway was a potential target in the treatment of colon cancers

    XRCC5 cooperates with p300 to promote cyclooxygenase-2 expression and tumor growth in colon cancers.
    Zhang Z, Zheng F, Yu Z, Hao J, Chen M, Yu W, Guo W, Chen Y, Huang W, Duan Z, Deng W., Free PMC Article

    11/26/2017
    inhibitory effects of 17-AAG on PGE2 levels in HT-29 colorectal cancer cells were mediated through modulating COX-2 and 15-PGDH expression.

    HSP90 Inhibition Suppresses PGE2 Production via Modulating COX-2 and 15-PGDH Expression in HT-29 Colorectal Cancer Cells.
    Mohammadi A, Yaghoobi MM, Gholamhoseinian Najar A, Kalantari-Khandani B, Sharifi H, Saravani M.

    03/11/2017
    The sequencing analysis revealed the presence of 17 variants, mostly causing non-synonymous changes in conserved amino acid residues, typically distributed in the MT-CO2 gene of MUTYH-associated polyposis patients (P < 0.0001), who frequently carried the hot spot m.7763G>A variant.

    Mitochondrial variants in MT-CO2 and D-loop instability are involved in MUTYH-associated polyposis.
    Errichiello E, Balsamo A, Cerni M, Venesio T.

    08/27/2016
    Results find that COA6 associates with COX2 and is crucial for its maturation and complex IV biogenesis. Also, COA6 interacts with the copper chaperone SCO1 which indicates that COA6 is intrinsically involved in the copper delivery process for COX2.

    COA6 is a mitochondrial complex IV assembly factor critical for biogenesis of mtDNA-encoded COX2.
    Stroud DA, Maher MJ, Lindau C, Vögtle FN, Frazier AE, Surgenor E, Mountford H, Singh AP, Bonas M, Oeljeklaus S, Warscheid B, Meisinger C, Thorburn DR, Ryan MT.

    07/16/2016
    Mutational analysis show a novel MTCO2 mutation 8249G>A pathogenic variation in Tunisian patients with mitochondrial myopathy.

    A novel MT-CO2 m.8249G>A pathogenic variation and the MT-TW m.5521G>A mutation in patients with mitochondrial myopathy.
    Mkaouar-Rebai E, Ben Mahmoud A, Chamkha I, Chabchoub I, Kammoun T, Hachicha M, Fakhfakh F.

    10/24/2015
    We also detected in 4 asthenospermic patients a double novels mutations, the first was found in COXII gene (m.8021 G/A) that was absent in normospermic infertile men.

    Two novel mutations in COII and tRNA(His) mitochondrial genes in asthenozoospermic infertiles men.
    Siwar BG, Myriam G, Afif BM, Emna MR, Nozha C, Afifa S, Faiza F, Leila AK.

    09/27/2014
    The presence of a non-synonymous variation in the COII strongly correlated with poor survival in patients with cytogenetically normal acute myeloid leukemia.

    Mitochondrial cytochrome c oxidase subunit II variations predict adverse prognosis in cytogenetically normal acute myeloid leukaemia.
    Silkjaer T, Nyvold CG, Juhl-Christensen C, Hokland P, Nørgaard JM.

    04/26/2014
    Protein modeling revealed loss of function mutations of ND6 and COX-II proteins in malignant vs benign tumors

    Mitochondria and tumors: a new perspective.
    Chintha R, Kaipa PR, Sekhar N, Hasan Q.

    03/22/2014
    COX-2 expression played an essential role in the proliferation and metastasis of tongue cancer.

    COX-2 Gene increases tongue cancer cell proliferation and invasion through VEGF-C pathway.
    Wang YH, Wu MW, Yang AK, Zhang WD, Sun J, Liu TR, Chen YF.

    08/25/2012
    Novel COII mutations responsible for maternally inherited nonsyndromic hearing loss

    Novel mitochondrial DNA mutations responsible for maternally inherited nonsyndromic hearing loss.
    Gutiérrez Cortés N, Pertuiset C, Dumon E, Börlin M, Hebert-Chatelain E, Pierron D, Feldmann D, Jonard L, Marlin S, Letellier T, Rocher C.

    07/14/2012
    The apoptotic index of pulmonary vascular endothelial cells was negatively correlated with COXII expression in patients with chronic obstructive pulmonary disease.

    [Cytochrome C oxidase expression and endothelial cell apoptosis in lungs of patients with chronic obstructive pulmonary disease].
    Yang M, Chen P, Peng H, Shen Q, Chen Y.

    12/17/2011
    firstprevious page of 2 nextlast